Cambridge Innovation Capital
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. CIC currently manages over £500 million and has invested in 30+ companies. We invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Cambridge Innovation Capital focuses on deep-tech and life sciences investments including AI, quantum tech, therapeutics, and medical diagnostics within the Cambridge ecosystem. As a growth equity and venture investor based in England, it supports high-growth IP-heavy companies.
Cambridge, England, United Kingdom
Venture Capital and Private Equity Principals
venture capital, growth equity
healthcare, technology, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech, digital health, genomics, proteomics
IP Commercialisation, Venture Capital, healthcare, technology
Done
Prospects
No prospects linked to this account.
Outreach History
Outreach sequencing tables are not yet in Supabase.